Similar articles

• [The sclerodermas].

  Huriez C. Huriez C. Lille Med. 1971 Dec;16(10):1358-69. Lille Med. 1971. PMID: 5160880 French. No abstract available.
• Progressive systemic sclerosis (scleroderma).

  [No authors listed] [No authors listed] JAMA. 1973 Apr 30;224(5 Suppl):711-6. JAMA. 1973. PMID: 4739736 No abstract available.
• Scleroderma and related disorders: therapeutic aspects.

  Denton CP, Black CM. Denton CP, et al. Baillieres Best Pract Res Clin Rheumatol. 2000 Mar;14(1):17-35. doi: 10.1053/berh.1999.0075. Baillieres Best Pract Res Clin Rheumatol. 2000. PMID: 10882212 Review.
• Systemic sclerosis (scleroderma). Clinical management of its major complications.

  Legerton CW 3rd, Smith EA, Silver RM. Legerton CW 3rd, et al. Rheum Dis Clin North Am. 1995 Feb;21(1):203-16. Rheum Dis Clin North Am. 1995. PMID: 7732169 Review.
• Thermographic and symptomatic effect of a single dose of sildenafil citrate on Raynaud's phenomenon in patients with systemic sclerosis: a potential treatment.

  Kumar N, Griffiths B, Allen J. Kumar N, et al. J Rheumatol. 2006 Sep;33(9):1918-9. J Rheumatol. 2006. PMID: 16960964 No abstract available.